Scientists discover a new way a disease-linked protein comes apart
Transthyretin amyloid disease (ATTR) is a progressive, life-threatening condition caused when the protein transthyretin (TTR) breaks apart and aggregates in the heart and other organs. One of the most common treatments, a drug called tafamidis, works by helping TTR stay intact—sl
Transthyretin amyloid disease (ATTR) is a progressive, life-threatening condition caused when the protein transthyretin (TTR) breaks apart and aggregates in the heart and other organs. One of the most common treatments, a drug called tafamidis, works by helping TTR stay intact—sl This story matters for Science & Discovery readers tracking certification. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. CertificationNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily certification signal